Manley; Peter J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Manley; Peter J..The latest application filed is for "heteroaryl allosteric modulators of nicotinic acetylcholine receptors".

Company Profile

2.24.24

Manley; Peter J. - Harleysville PA
Manley; Peter J. - Harleysviller PA
Manley, Peter J. - Phoenixville PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heteroaryl allosteric modulators of nicotinic acetylcholine receptors Grant 11,198,687 - Bell , et al. December 14, 2	2021-12-14
Heteroaryl Allosteric Modulators Of Nicotinic Acetylcholine Receptors App 20200262826 - Bell; Ian M. ; et al.	2020-08-20
Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their use Grant 10,072,003 - Arasappan , et al. September 11, 2	2018-09-11
TETRAHYDRONAPHTHYRIDINE DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE App 20170305902 - Arasappan; Ashok ; et al.	2017-10-26
Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use Grant 9,663,506 - Bungard , et al. May 30, 2	2017-05-30
Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use Grant 9,636,337 - Bungard , et al. May 2, 2	2017-05-02
Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders Grant 9,399,651 - Wolkenberg , et al. July 26, 2	2016-07-26
Quinoline Carboxamide and Quinoline Carbonitrile Derivatives as mGluR2-Negative Allosteric Modulators, Compositions, and Their Use App 20160159744 - Bungard; Christopher James ; et al.	2016-06-09
Quinoline Carboxamide and Quinoline Carbonitrile Derivatives as mGluR2-Negative Allosteric Modulators, Compositions, and Their Use App 20160158217 - Bungard; Christopher James ; et al.	2016-06-09
Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders Grant 9,309,199 - Wolkenberg , et al. April 12, 2	2016-04-12
Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use Grant 9,278,960 - Bungard , et al. March 8, 2	2016-03-08
Inhibitors Of Catechol O-methyl Transferase And Their Use In The Treatment Of Psychotic Disorders App 20150299227 - Wolkenberg; Scott ; et al.	2015-10-22
Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders Grant 9,024,032 - Wolkenberg , et al. May 5, 2	2015-05-05
QUINOLINE CARBOXAMIDE AND QUINOLINE CARBONITRILE DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE App 20140309227 - Bungard; Christopher James ; et al.	2014-10-16
Imidazoisoindole neuropeptide S receptor antagonists Grant 8,541,595 - Manley , et al. September 24, 2	2013-09-24
Inhibitors Of Catechol O-methyl Transferase And Their Use In The Treatment Of Psychotic Disorders App 20130084346 - Wolkenberg; Scott ; et al.	2013-04-04
Quinolone neuropeptide S receptor antagonists Grant 8,389,720 - Barrow , et al. March 5, 2	2013-03-05
Inhibitors Of Catechol O-methyl Transferase And Their Use In The Treatment Of Psychotic Disorders App 20130005744 - Wolkenberg; Scott ; et al.	2013-01-03
Quinolone Neuropeptide S Receptor Antagonists App 20110212946 - Barrow; James C. ; et al.	2011-09-01
Imidazoisoindole Neuropeptide S Receptor Antagonists App 20110212941 - Manley; Peter J. ; et al.	2011-09-01
Inhibitors of Akt activity Grant 7,910,561 - Arruda , et al. March 22, 2	2011-03-22
Potassium channel inhibitors Grant 7,879,839 - Dinsmore , et al. February 1, 2	2011-02-01
Inhibitors of Akt activity Grant 7,750,151 - Bilodeau , et al. July 6, 2	2010-07-06
Decahydroquinoline Analogs As Cb2 Receptor Modulators, Useful In The Treatment Of Pain, Respiratory And Non-respiratory Diseases App 20100099673 - Bilodeau; Mark T. ; et al.	2010-04-22
Inhibitors of Akt activity Grant 7,544,677 - Bilodeau , et al. June 9, 2	2009-06-09
Inhibitors of Akt Activity App 20080287457 - Arruda; Jeannie M. ; et al.	2008-11-20
Inhibitors of Akt Activity App 20080280899 - Bilodeau; Mark T. ; et al.	2008-11-13
Potassium Channel Inhibitors App 20080090794 - Dinsmore; Christoph J. ; et al.	2008-04-17
Inhibitors of Akt Activity App 20070254901 - Bilodeau; Mark T. ; et al.	2007-11-01
Inhibitors of Akt activity Grant 7,223,738 - Bilodeau , et al. May 29, 2	2007-05-29
Tyrosine kinase inhibitors Grant 7,115,597 - Bilodeau , et al. October 3, 2	2006-10-03
Tyrosine kinase inhibitors Grant 6,958,340 - Bilodeau , et al. October 25, 2	2005-10-25
Inhibitors of akt activity App 20050222155 - Bilodeau, Mark T. ; et al.	2005-10-06
Vitronectin receptor antagonists Grant 6,881,736 - Manley , et al. April 19, 2	2005-04-19
Tyrosine kinase inhibitors App 20040235867 - Bilodeau, Mark T. ; et al.	2004-11-25
Tyrosine kinase inhibitors App 20040220201 - Bilodeau, Mark T. ; et al.	2004-11-04
Tyrosine kinase inhibitors App 20040063720 - Bilodeau, Mark T. ; et al.	2004-04-01
Tyrosine kinase inhibitors Grant 6,586,423 - Bilodeau , et al.	2003-07-01
Tyrosine kinase inhibitors Grant 6,586,424 - Bilodeau , et al. July 1, 2	2003-07-01
Tyrosine kinase inhibitors App 20030064996 - Bilodeau, Mark T. ; et al.	2003-04-03
Tyrosine kinase inhibitors App 20020147203 - Bilodeau, Mark T. ; et al.	2002-10-10
Vitronectin Receptor Antagonists App 20020147334 - Miller, William H. ; et al.	2002-10-10
Tyrosine kinase inhibitors App 20020137755 - Bilodeau, Mark T. ; et al.	2002-09-26